Tilray Brands Inc (TLRY)
$1.89
0.03 (1.56%)
TLRY Stock Quote Delayed 30 Minutes
Why There’s No Rush to Buy Tilray Stock Anytime Soon
TLRY stock is down big since the passage of the MORE Act, and that's a sign of more troubles to come for Tilray stock.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
1.38B
PE Ratio
-18.90
EPS
-0.1
Volume (Avg. Vol.)
17.93M
Day's Range
$1.89 - $1.96
52-Week Range
$1.60 - $3.40
Dividend & Yield
N/A (N/A)
TLRY Stock Predictions, Articles, and Tilray Brands Inc News
Investors Should Stop Calling Tilray Stock a Top-Tier Marijuana Name
Hope for U.S. legalization helped Tilray stock, but financial conditions indicate it may struggle to remain top-tier or perhaps, survive.
Don’t Buy Tilray Stock Despite the Cannabis Rebound
Despite the steep discount in Tilray stock, this remains a name to avoid because neither the fundamentals nor technicals imply a positive trajectory.
As Canopy Growth Stock Stalls, Pot Investors Mull What Will Happen Next?
Canopy Growth faces plenty of tough problems ahead. So too, do its competitors. When will outsized growth return to CGC?
Don’t Bet on Tilray Stock Surviving the Cannabisphere Meltdown
Tilray stock is a minefield of risk. "Cannabis 2.0" could improve their fortunes. But a myriad of risks remain. With $450 million in convertible notes coming due in 2023, TLRY needs to improve its cash situation. Unless the company is swimming in green (cash, not pot) by then, Tilray will need a capital infusion to stay afloat. Add in potential selling pressure from Privateer shareholders unloading their position, and there's too many fleas on this dog for my taste.
The Manitoba Harvest Acquisition Saved Tilray Stock This Quarter
Tilray’s acquisition of Manitoba Harvest should help Tilray stock. TLRY stock may perform better than other marijuana stocks.
Stock Market Today: Cannabis Gets Crushed
Walmart and Cisco stock beat on earnings, but fell on Thursday. Here's what happened in the stock market today.
Tilray Stock Has Fallen and Can’t Get Up
Tilray stock, along with the rest of the marijuana sector, have fallen out of favor and won't get back up. They need consistent profit.
High Hopes: Tilray Stock Needs a Miracle to Finish 2019 Strong
Investors justifiably have low expectations for TLRY stock ahead of quarterly earnings. Here's the outlook for Tilray through the end of 2019.
The Bubble Has Burst, But Tilray Stock Is More Than a Penny Stock
Tilray stock is hovering near its IPO level. The cannabis bubble has burst, but that doesn't mean TLRY should be treated like a penny stock.
Why the Slide of Tilray Stock May Continue
Tilray stock has been stuck in a multi-quarter decline, and the fundamentals imply that the slide of TLRY stock may not be over.
Is Tilray Stock About to Stage a Comeback?
Throughout 2019, Tilray stock and its cannabis peers have hemorrhaged market value. But a development within the sphere of cancer research has brought legitimacy to both TLRY and the broader industry.
Tilray Stock Short Sellers Need to Be Careful
Tilray has been one of the most profitable cannabis stocks to short in the past year. However, shorting TLRY stock at this point is a dangerous play.
Don’t Expect Tilray Stock to Recover Anytime Soon
Tilray's cash burn and regulatory issues make Tilray stock unattractive. Investors shouldn't buy TLRY stock yet.
Shareholders Worry as Tilray Stock Approaches IPO Price
If Tilray stock breaks the $17 level, the IPO price will become a resistance level. Investors should also expect short selling there.
Investors Beware: Tilray Stock Might Not Be Done Dropping
Tilray stock probably has further to fall since TLRY must overcome further funding obstacles before it can become a profitable company.
With Profitability Nowhere in Sight, Tilray Stock Has Further to Fall
Tilray stock tumbles as investors demand profitability. Tilray, like other cannabis stocks, is stuck in a death spiral as long as the copmany can't produce profits.
Plunging Tilray Stock Shows Just How Much Sentiment Has Changed
Tilray stock keeps falling and now is nearing its IPO price. Trading in TLRY stock shows how much faith investors have lost in pot stocks.
Has Tilray Stock Finally Hit Rock-Bottom?
It’s been absolutely grueling for Tilray stock. It seems like nothing can help shares. But interestingly enough, this may be setting up a good entry point for TLRY.
Tilray Stock Hammered as Investors Turn on Cannabis Producers
Revised earnings guidance for Hexo spooked the market and hit cannabis stocks, with Tilray stock closing down 13.5% on Thursday.
